As a prophylactic agent, Rimactal may be prescribed to prevent certain meningococcal infections.
As part of adjunct therapy, this drug can be prescribed to treat MRSA (methicillin resistant Staphylococcus aureus).
If you are unsure why you have been prescribed a therapy cycle with this drug, you are advised to ask your prescriber for additional, more detailed information.
Rimactal is a bacteriostatic antibiotic based on the main ingredient Rifampicin, of the Rifamycin class of drugs.
Rimactal is a medicine commonly prescribed for the treatment of bacterial infections caused by susceptible invasive agents - including leprosy and tuberculosis.
The active substance is a semi synthetic derivative from Streptomyces mediterranei.
This drug is available for oral administration under the form of tablets.
This medicine is efficient in treating infections with Neisseria gonorrhoeae, Legionells pneumophila and Haemophilus influenzae - however due to the fact that the above invasive agents are able to rapidly develop a resistance to Rimactal, this drug may not be prescribed in monotherapy for the treatment of these infections.
As such it is strongly recommended that you ask your personal health care provider to assist you in weighing the risks and benefits of the treatment.
He or she may also inform you regarding alternative therapy methods.
If you are not sure whether or not you may be allergic to any of its ingredients, check with your personal health care professional.
Rimactal may not be administered to patients suffering from alcohol addiction, to patients with severe hepatic impairment or to patients with jaundice.
Rimactal may not be administered to patients that are known or suspected to have a hypersensitivity to any of the excipients of this pharmaceutical product.
Until now, studies have not revealed whether or not this drug is safe to use during pregnancy or lactation.
It is strongly recommended that you ask your prescriber to provide directions regarding the proper administration procedure for Rimactal. He or she will be able to offer detailed information on the appropriate intake procedure.
The Rimactal intake directions provided by your health care professional may differ from the information in this guide. If this is the case, you should disregard the above information and follow your physician's indications.
You should swallow the Rimactal tablets whole, without crushing, chewing or breaking them. If you experience stomach upset, you may take the tablets with a full glass of water or with food to reduce the gastric discomfort. Take he medicine at around the same time each day for the therapy to yield the best results.
The above information is with informational purpose only. Your prescriber may direct the use of a different Rimactal dosage. If this is the case, follow your personal physician's directions.
In the case of tuberculosis, the average Rimactal dosage employed is a maximum of 600 mg per day, or of 15 mg per kg of body weight with a maximum of 900 mg administered two or three times per week. For leprosy, the dosage is of 600 mg administered once per month if Rimactal is administered in a monotherapy regimen or once per day when combined with other medication. For infections with Haemophilus influenzae, type B, the common dosage is of 20 mg per kg of body weight with a maximum of 600 mg per day, administered daily for four days.
An overdose with Rimactal is accompanied by the appearance of such symptoms as nausea and vomiting, anemia, confusion, lethargy, dizziness, vision blurring and a discoloration of the skin, mucous membranes and bodily fluids, which take on a reddish color. If left unattended or if the patient has been exposed to excessive quantities of the drug, the symptoms will worsen rapidly, causing severe complications and even death. If you suspect an overdose with this medicine, it is recommended that the affected individual is transported to the nearest medical facility even if no symptoms are present. Emergency medical assistance may be required.
It is recommended that you set up a Rimactal intake schedule that fits your daily agenda. Taking the medicine at around the same time each day may reduce the chances of accidentally forgetting to take your medication, and also will allow for optimum therapeutical results to be achieved.
If you have accidentally forgotten to take your dose of Rimactal, you are advised to take it as soon as you remember about it; however, if this happens too close to the time of another intake, it is best to completely skip the missed dose and take the next one on time. You should not take a double dose of the medicine in an attempt to make up for a missed dose.
While following a therapy course with Rimactal, you may experience a number of adverse reactions. The most common of these are mild and can be expected to go away within a short period of time. However, in rare cases, the adverse reactions are severe and require immediate medical assistance. Examples of such adverse reactions are hypersensitivity reactions (allergic reactions), gastrointestinal reactions, shock, breathing trouble, acute anemia, renal failure, body fluid discoloration, chills and fever, arthralgia.
Rimactal may interact with a variety of drugs and medicines, with different possible detrimental effects. Examples of drugs that may affect or be affected by this drug are antacids, beta blockers, oral contraceptives, certain heart medication (Mexiletine, Disopyramide, Quinidine, Lorcainide, Verapamil), medicines employed in the treatment of hypoglycemia, and so on.
Other Brand Names
In some countries Rimactal may also be known as:
- Rifacom E-Z;